LONDON, UK. July 20th, 2026 – Sapyen and IVF London today announced a strategic partnership to expand access to home-based male fertility diagnostics across the United Kingdom, supporting earlier assessment and more accessible pathways for patients beginning their fertility journey. The partnership will see Sapyen become IVF London’s exclusive provider
CALIFORNIA, US. June 4, 2026 – Sapyen, the world’s leading male fertility diagnostics company, today announced a long-term strategic partnership with My Surrogacy Journey, one of the most prominent and internationally recognised organizations in global surrogacy. The partnership will see Sapyen become a key fertility testing partner to My Surrogacy
ST ALBANS, UK. May 18th, 2026 – Global male fertility company Sapyen has launched a new fertility preservation programme in the United Kingdom, allowing men to freeze sperm for £1 for the first year. The launch marks a significant shift in how male fertility preservation is positioned and accessed. Sapyen’s
LONDON, UK. March 30th, 2026 – Fertility testing in the UK is starting to look very different. Instead of multiple appointments, referrals, and weeks of waiting, a new model is emerging where both partners can test at home, at the same time, and walk into their first clinic appointment with
Melbourne, Australia. March 17th, 2026 – A structural change is taking place at the front door of UK fertility care. For the first time, a leading fertility clinic has redesigned how treatment begins so that both partners in a couple complete clinical fertility screening at home, before attending a first
San Francisco, US. November 17th 2025 – IVI RMA North America, one of the world’s most influential fertility networks, has entered into a multi-year exclusive agreement with Sapyen to incorporate home-based male fertility testing. The move reflects a broader shift among major fertility networks toward integrating remote diagnostics that can